Alanbell Health Files IPO Prospectus Amid Over 300% Revenue Surge, Led by Former Mayo Clinic Cardiovascular Lab Director

With the rising incidence of chronic diseases in China and worldwide, we have entered an era of “chronic disease pandemic.” Consequently, home-based, remote, digital, and precision healthcare will become key trends in the future development of the medical and health industry.

“In our digital health business, we adhere to standardized and universal R&D principles, building a fully online health management service platform that integrates testing, reporting, interpretation, and intervention management, ensuring all digital health products operate on the same workflow and system.”Currently, any of our digital health products can be fully developed from design to launch within just one month.” introduced Yu Jun, CEO of Alanbell.

Alanbell is a medical institution dedicated to enhancing patients' quality of life and longevity through personalized preventive medicine. Adhering to the professional principles of rigorous medicine, the company integrates cutting-edge approaches in laboratory medicine, clinical medicine, functional medicine, and an integrated holistic diagnostic and therapeutic philosophy, while operating its own high-standard laboratory.Focusing on the management of critical risk thresholds in chronic diseases through “quantifiable, visualizable, and manageable” approaches, and integrating a membership model, concierge service, and a high-quality medical resource ecosystem, we provide highly personalized “Basic-Better-Best” health coaching plans.

In 2017, Jiachen Capital invested in Salveo Laboratories in the United States, focusing primarily on screening for pre-disease conditions and chronic disease risks. In 2019, Jiachen Capital further invested in WellcomeMD, a U.S.-based chain of high-end family physician service providers catering to affluent clientele. Leveraging specialized laboratory testing technologies, WellcomeMD conducts early-stage and even pre-symptomatic risk detection, followed by subsequent intervention, management, and treatment services. This approach helps high-net-worth individuals maintain optimal health and quality of life, thereby preventing premature onset of disease or aging. After validating its service model and technological advancements, Jiachen Capital introduced the business models of Salveo Laboratories and WellcomeMD clinics to China, establishing operations in Chengdu. This included the construction of a 1,500-square-meter central laboratory and two medical diagnostic and treatment centers, each spanning 1,500 square meters.

Central Laboratory Internal Environment: Currently Capable of Testing Over 100 Specialized Assays

In December 2021, Alanbell’s central laboratory and its first medical diagnosis and treatment center, located by Xinglong Lake in Tianfu New Area, Chengdu, were officially opened as a key innovative healthcare project introduced by the Tianfu New Area government. In August 2022, the Alanbell Xiangnanli Medical Diagnosis and Treatment Center commenced operations in the CBD core of Wuhou District, Chengdu, expanding its business reach from the Sichuan-Chongqing region to nationwide coverage.

First Medical Diagnosis and Treatment Center (Xinglong Lake Branch)

CEO Yu Jun officially joined Alanbell in 2023. Mr. Yu holds a Master’s degree in Healthcare Management from Tulane University and is a Certified Professional in Healthcare Quality (CPHQ). He previously served as an internist at the Affiliated Hospital of PLA General Hospital (301 Hospital), Director of Medical Performance Management at Washington Hospital, Consulting Director and Head of Life Sciences for Greater China at IBM Consulting, and Managing Director of Greater China for the Population Health Division at Aetna Insurance. Starting his career as a clinician, Mr. Yu has since worked in diverse areas including healthcare institution management, digitalization, and health insurance, accumulating over 20 years of experience in the broader healthcare industry.

According to Yu Jun, his decision to join Alanbell was primarily driven by the company’s core competitiveness and its values, which are largely aligned with those in the broader health and wellness sector. “Alanbell boasts a comprehensive diagnosis and treatment system, supported by globally patented proprietary laboratory testing technologies. Empowered by Sevive’s algorithms from the United States, it enables integrated analysis and interpretation of multiple indicators, establishing strong ‘trinity’ core competitiveness in the fields of health management, disease prevention, and anti-aging,” Yu Jun told VCBeat.

Alanbell has assembled a highly qualified multinational core team in the medical and health sector by bringing together medical experts from leading international institutions and collaborating with domestic physician teams.

Among them, Dr. Guo Peng, the Chief Medical Officer, holds a Doctor of Medicine degree from Sichuan University. He serves as Vice Chairman of the Targeted Therapy Professional Committee and as a Standing Committee Member of the Chemotherapy Professional Committee under the Sichuan Anti-Cancer Association. He is also a Distinguished Expert in Medical Management appointed by the Sichuan Provincial Health Commission, one of the eighth cohort of Academic and Technical Reserve Talents in Sichuan Province, and a recipient of the Special Government Allowance granted by the Wuhou District People’s Government of Chengdu.

Furthermore, the team includes associate chief physicians from renowned Grade A tertiary hospitals, registered dietitians certified in both China and the United States, and professional sports rehabilitation coaches. The company’s domestic team currently comprises over 60 members,Among them, more than 45% hold a master’s degree or higher, and over 25% of employees have overseas work or study experience.

The physician team at Alanbell has received training in traditional medicine, integrative medicine, and functional medicine. They formulate and implement optimal treatment plans based on patients’ clinical presentations and biomarker results across various stages of disease.

Experts from the Medical Division of Alanbell have established a relatively unique and effective system for disease prevention and scientific anti-aging through extensive literature review and research,We advocate a three-step progressive health coaching philosophy, known as the “3B” concept. The three Bs stand for Basic, Better, and Best.

“The background behind this concept is that China’s broader health industry, particularly the health management sector, is fraught with mixed quality. Many institutions offer health management and anti-aging services that lack scientific rigor, focusing instead on single-product offerings without providing personalized classification based on customer profiles and their respective disease stages,” introduced Yu Jun.Alanbell adopts a membership-based, long-term companion model. Unlike the many short-term, one-off service models prevalent in the market, it implements refined customer segmentation and develops phased, tailored plans based on individual age, health status, disease progression, and health and anti-aging needs, thereby achieving personalized intervention management.

Specifically,“BASIC” refers to the risk assessment, treatment, and intervention for chronic diseases., for clients currently in the disease stage, the primary objective is to control disease progression and restore physiological health to a near-normal or normal state. In this process, Alanbell determines the baseline status of clients' chronic conditions by measuring various novel biomarkers for chronic diseases, including the risks and status of cardiovascular disease, diabetes, and gut health. Interventions and pharmacological treatments are implemented based on biomarker results, clinical manifestations, and medical history, aiming to restore patients' biomarkers to healthy levels. Once the underlying chronic diseases are controlled, patients will proceed to the second phase—"BETTER."

“BETTER” corresponds to functional anti-aging management.At this stage, Alanbell will employ comprehensive biomarker analysis, clinical stress testing, and other assessments to determine clients’ endocrine-metabolic status, hormone levels, and overall psychological and physiological stress levels. Based on these findings, Alanbell’s physicians and healthcare professionals will collaborate with patients to develop optimal treatment and management strategies aimed at alleviating stress and improving endocrine health and hormonal function, thereby slowing the aging process.

“BEST” refers to cellular-level anti-aging medicine.At this stage, professionals will assess the client’s mitochondrial function, the extent of cellular functional decline, overall immune status, and resistance to infectious diseases. Alanbell will leverage novel technologies and therapies to protect and enhance mitochondrial function, delay cellular functional decline, and clear senescent and apoptotic cells to bolster immune function.

Overall, Alanbell employs globally patented proprietary laboratory testing technologies and comprehensive clinical health assessments to promptly identify disease risks and residual risks. By integrating customized holistic health services, lifestyle interventions, imported medical-grade products, and specially formulated bioidentical products from specialized institutions, the company helps clients manage disease risks and combat the aging process. The company has assembled a professional team comprising physicians, health managers, registered dietitians, exercise rehabilitation specialists, and nurses, who deliver multi-to-one personalized services to clients.

Client Exercise Room: One-on-One Guidance by Sports Rehabilitation Therapist

Alanbell comprises two core business segments: one provides comprehensive, personalized health management services to high-net-worth individuals; the other is its digital health business, which targets the mass market, including middle-income groups and wage earners.Leveraging AI algorithms and Alanbell Labs’ globally patented specialized testing technologies, and adopting a telemedicine service model, we deliver fully online services encompassing testing, result retrieval, report interpretation, and intervention guidance. Our aim is to achieve precise health management with broader coverage, lower costs, and higher efficiency, targeting customers across China and even globally.

Alanbell Medical Testing Center serves as a critical technical foundation for Alanbell’s personalized health and anti-aging services. The center was established under the leadership of Dr. Joseph P. McConnell, former Director of the Cardiovascular Laboratory at the Mayo Clinic in the United States., the specialized testing services it offers originate from the U.S.-based Savoy Laboratory and its American R&D team. Under the close guidance of U.S. experts, these services were implemented at the Alanbell Medical Testing Center following rigorous validation studies;The combined testing of specialized and general examinations, along with a unique reporting format, provides effective data support and practical guidance for the early detection, diagnosis, intervention, and treatment of chronic diseases.; Currently, Alanbell Medical Testing Center is collaborating with Alanbell Medical Diagnosis and Treatment Center to build a chronic disease management database in China.

According to Yu Jun, compared with most hospitals and testing institutions currently, Alanbell can detect risks before customers exhibit obvious clinical symptoms, enabling early intervention and reversal of the disease course. “Therefore, I believe that Western medicine can also ‘prevent disease before it arises.’ It is commonly believed that Traditional Chinese Medicine (TCM) achieves the concept of ‘the superior physician prevents disease,’ while Western medicine merely treats symptoms as they appear—addressing headaches when the head hurts and foot pain when the feet hurt. This perception actually stems from the historical development of Western medicine, which has been characterized by laboratory-based diagnostics and specialized subdivisions,” Yu Jun explained to VCBeat. “Over the past decade or so, modern Western medicine has increasingly moved toward multidisciplinary integration, including the currently proposed ‘holistic medicine’ model. I believe this represents an evolution toward the holistic thinking inherent in TCM.” Yu Jun believes that in the future, Western medicine will shift from diagnosis and treatment toward disease prevention and overall health, thereby better serving customer groups who are concerned about their health status and have anti-aging needs.

In terms of testing, Alanbell has established more granular risk intervals for clinical test indicators. Unlike the conventional three-tier classification (low, medium, and high), Alanbell employs a five-tier stratification: low, slightly low, optimal, slightly high, and high.“The ‘normal range’ as defined in clinical practice does not equate to optimal health; therefore, we have further subdivided the clinical normal range into three categories—low-normal, optimal, and high-normal—to facilitate timely intervention and management when clients are in the early stages of risk.”,” said Yu Jun.

Meanwhile, Alanbell can provide multi-parameter interpretation of test results, analyzing and explaining health status from the perspective of combinations and correlations among two to three indicators. In contrast, most hospitals and checkup centers currently offer only single-parameter interpretation. According to Yu Jun, this analytical advantage of Alanbell is rare in China.

Specialized Mass Spectrometry Testing Area: Two sets of liquid chromatography-tandem mass spectrometers, with detection accuracy reaching the picogram level.

In addition, Alanbell offers advanced specialized testing services, such as food sensitivity testing for over 170 items, lipoprotein particle count testing, salivary melatonin testing, small dense low-density lipoprotein cholesterol (sdLDL-C) testing, and red blood cell folate testing. It can also assess clients’ physiological age from the perspectives of methylation and immunity. Meanwhile, the test results provide data support for precise nutritional supplementation. “We develop personalized supplement regimens for clients based on their biomarker test results, and we continuously monitor and dynamically adjust the plans. This approach ensures that clients do not simply continue taking products indefinitely after purchase without regard to dosage or actual efficacy,” introduced Yu Jun.

Regarding the future development prospects of the industry, Yu Jun stated that the anti-aging and disease prevention sectors may reach a market tipping point within the next 5 to 10 years. “Since the pandemic, public awareness and demand for disease prevention and health management have increased significantly, marking a stark contrast to the pre-pandemic era.” Meanwhile, from a supply-side perspective, various anti-aging therapies have advanced rapidly over the past decade and are expected to be widely adopted in clinical practice and commercial applications within the next 5 to 10 years.

In Q1 of this year, Alanbell’s business metrics grew more than threefold year over year. In the near term, Alanbell will continue to optimize its business model and refine standardized service processes and talent development mechanisms, laying the groundwork for multi-regional expansion. Over the medium to long term, Alanbell will expand its presence across China and into overseas markets, leveraging a robust digital system to become a platform-level partner in the broader health and wellness sector.In the future, Alanbell will continue to uphold an open mindset, looking forward to collaborating with more industry partners to expand and deepen the domestic market for disease prevention, intervention, and anti-aging, thereby providing consumers with higher-quality health management services.